Search for: "Mylan, Inc." Results 141 - 160 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2012, 8:43 pm by Patent Docs
Mylan Pharmaceuticals, Inc. 0:12-cv-60704; filed April 20, 2012 in the Southern District of Florida • Plaintiffs: Apotex,... [read post]
14 Nov 2016, 2:01 pm by Susanna Leighton
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
29 Aug 2016, 5:02 am by Susanna Leighton
Just last week, Mylan Inc. decided it was a good idea to raise the price of the life-saving EpiPen, which is used to stop a person from going into anaphylactic shock after experiencing an allergic reaction. [read post]
4 Sep 2016, 8:42 am by Susanna Leighton
With the price increase of the live-saving EpiPen from $100 per two-pack to over $600 per two-pack last week (conveniently in August when most parents who have children with allergies are set to purchase their necessary supplies of the drug before school starts), the company responsible for the hike, Mylan Inc., is backing away fromThe post EpiPen Increase Based in Greed, Not Need appeared first on Legal Reader. [read post]
29 Aug 2004, 3:55 pm
West Virginia US District Judge Irene Keeley may rule as early as Monday on the legality of "authorized generics" in a dispute between the FDA and Mylan Laboratories, Inc.. [read post]
10 Nov 2022, 1:25 pm by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
23 Jul 2018, 2:38 pm by Jason Rantanen
Mylan Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., AKORN, Inc. [read post]